Healthcare and Medicine

Netherlands Twentysix Groundbreaking Tender

📄 Tender ID: 464588274 📅 Published: 11 Aug 2021

📋 Tender Overview

The Board of NWO Domain Science has awarded 26 applications in the Open Competition Domain Science - XS.Each project could apply for a maximum of 50.000 euros. The themes vary from research into heart failure the 3D printing of aluminum and using nanoparticles for use in medicines. The XS category emphatically strives to encourage curiosity-driven and bold research involving a relatively quick analysis of a promising idea. In ENW XS the applicants are also the assessors in the assessment process. The budget for the Open Competition Domain Science XS round 2021 has been increased so that 26 applications can be awarded with each deadline. De next deadline is on 14 September 140000 CEST.The summaries of the approved projects are listed below. The information for one project will be added later due to administrative reasons. The projects are listed in alphabetical order3D engineered brain cancer microenvironments for proton radiobiologyDr. A. Accardo Technische Universiteit DelftGlioblastoma is a devastating cancer of the brain with an extremely poor prognosis. A relatively new cancer treatment is radiotherapy with proton beams which can be targeted to destroy cancer cells while sparing surrounding healthy tissue. However despite the treatments compelling biological and medical rationale little is known about the effects of protons on glioblastoma at the cellular level. We will pioneer the most realistic three-dimensional in-vitro model of glioblastoma networks to date by exploiting two-photon polymerization. The model will pave the way for routine and even per-patient assessment of the efficiency of proton therapy on glioblastoma cells.Real-time monitoring of T-cells to identify determinants of immune therapy failureDr. H.E. Balcioglu Erasmus MCEmergence of immunotherapy has changed the treatment and patient outcome for various tumor types. Unfortunately patient response and reasons behind failure of response is currently hard to assess. T-cells actively recognize and kill tumor cells. Additionally their migration towards tumors and accumulation and activation in the tumor is crucial for the success of immunotherapy. Here with patient based tumorT-cell 3D co-culture we aim to capture the real-time dynamics of T-cells in detail to understand therapy response. This will enable us to accurately predict treatment response in patients and allow us to generate new combinational treatment modalities for non-responsive patients.Oral Selenium supplementation to treat severe heart failure do they get itDr. N. Bmer Universitair Medisch Centrum GroningenAn aberrant equilibrium of circulating molecules like micronutrients eg. Selenium in the patients blood are closely associated with the development and progression of heart failure. Restoring the balance could be a potent treatment strategy. Assessing treatment efficiency of oral selenium supplementation at the target tissue in human subjects is very innovative in the field of heart failure. When proving that oral selenium supplementation indeed reaches the heart this will be the exciting starting point for conducting thorough clinical trials assessing the effect of oral Se supplementation on clinical symptoms and prognosis in HF patients.3D Printing of non-printable high strength aluminium and magnesium alloys PRINT4ALDr. ir. T.C. Bor Universiteit Twente3D printing or additive manufacturing of many high strength-low weight aluminium and magnesium alloys is not possible with additive manufacturing processes in which the alloy is melted. Metallurgical problems such as cracks and pores often occur during solidification of the liquid alloy yielding inferior material properties.In this research project printing of these non-printable high strength materials is to be achieved through an innovative solid-state approach avoiding the liquid phase. The research aims both at the understanding and prediction of the metallurgical phenomena occurring under the extreme process conditions and the development of new classes of materials with exceptional properties.RNA computational logic to classify and remove senescent cellsProf. dr. R. Brock Radboud Universitair Medisch CentrumSenescent cells cause a variety of age-related diseases. No therapy exists that can selectively remove them. To achieve selective removal we will employ a biological computational circuit based on RNA-encoded logic gates that measure microRNAs RNAs not coding for proteins inside cells and thereby classify cells as being senescent or not. When classified as senescent a therapeutic programme will be executed leading to selective removal of these cells. The circuit will be delivered by nanoparticles to liver cells which also can easily be reached in humans in vivo indicating the potential for rapid clinical translation and alleviation of disease-caused suffering.Bioinspired tools for a more efficient drug discovery processDr. ing. D.L.J. Broere Universiteit UtrechtTo make sure that ingested medicine can leave the body our livers use special tools that modify the medicines structure to make it more soluble in water. However sometimes these modifications can lead to undesired side effects. Therefore when developing a new medicine it is important to make the various modified medicines and investigate how they affect a patient. This process takes a lot of time costs a lot of money and slows down the medicine development process. In this project the researchers aim to develop a chemical tool that makes it easier to make these modified medicines.

🔍 Key Information

📄
Tender Reference No.
464588274
📅
Publication Date
11 Aug 2021
🌐
Sector
Healthcare and Medicine
📝
Notice Type
News
📍
Location
Netherlands

📁 Documents & Downloads

No documents found

🏷️ CPV

No CPV found

Need help with this bid?

Our bid experts can help you find, evaluate & win more tenders.

🎧 Talk to Bid Expert
🕒 Submission deadline
0
days remaining · 11 Aug 2021
🔔 Set Alert

🧭 Quick Facts

Authority N/A
Country Netherlands
State / UT N/A
Tender Type Procurement News
Currency N/A
Similar Tenders
Loading similar tenders…